SCHEMBL488926

SCHEMBL488926

Cc1c(O)c(O)c2cc3ccccc3cc2c1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NQO1 P15559 1/20 0.40
CYP2A6 P11509 4/20 0.39
CYP1A2 P05177 4/20 0.39
TDP1 Q9NUW8 1/20 0.39
MEN1 O00255 1/20 0.39
NPC1 O15118 1/20 0.39
HSP90AA1 P07900 1/20 0.39
RAB9A P51151 1/20 0.39
KMT2A Q03164 1/20 0.39
LMNA P02545 1/20 0.39
HTT P42858 1/20 0.39
MAPT P10636 1/20 0.37
PTPN22 Q9Y2R2 1/20 0.37
TSHR P16473 1/20 0.37
TRPM4 Q8TD43 1/20 0.37
ALDH1A1 P00352 2/20 0.36
PKM P14618 1/20 0.36
KDM4E B2RXH2 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1976533 0.85 CYP2A6 (0.50) NQO1CYP2A6CYP1A2TDP1NPC1
SCHEMBL28542519 0.83 NQO1 (0.48) NQO1CYP2A6CYP1A2TDP1NPC1
SCHEMBL28546208 0.81 NQO1 (0.36) NQO1CYP2A6CYP1A2TDP1MEN1
SCHEMBL7501835 0.80 NQO1 (0.46) NQO1CYP2A6CYP1A2TDP1NPC1
Methyl Alcohol SCHEMBL27872622 0.80 NQO1 (0.46) NQO1CYP2A6CYP1A2TDP1MEN1
SCHEMBL687284 0.80 NQO1 (0.46) NQO1CYP2A6CYP1A2TDP1NPC1
SCHEMBL4642683 0.80 CYP2A6 (0.50) NQO1CYP2A6CYP1A2TDP1NPC1
SCHEMBL29853846 0.80 CYP2A6 (0.50) NQO1CYP2A6CYP1A2TDP1NPC1
SCHEMBL2115679 0.80 CYP1A2 (0.50) NQO1CYP2A6CYP1A2MEN1NPC1
SCHEMBL28547051 0.79 NQO1 (0.39) NQO1CYP2A6CYP1A2TDP1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8105836-B2 Chemical inhibitors of mismatch repair MORPHOTEK, INC. (US) 2012-01-31 US claimed
EP-1351565-B1 CHEMICAL INHIBITORS OF MISMATCH REPAIR MORPHOTEK INC (US) 2011-03-16 EP claimed
US-6982169-B2 Chemical inhibitors of mismatch repair MORPHOTEK, INC. (US) 2006-01-03 US claimed
EP-1351565-A4 CHEMICAL INHIBITORS OF MISMATCH REPAIR MORPHOTEK INC (US) 2005-05-25 EP claimed
EP-1417329-A4 METHODS FOR GENERATING ANTIBIOTIC RESISTANT MICROBES AND NOVEL ANTIBIOTICS MORPHOTEK INC (US) 2005-05-11 EP claimed
EP-1417329-A1 METHODS FOR GENERATING ANTIBIOTIC RESISTANT MICROBES AND NOVEL ANTIBIOTICS Morphotek Inc. (US) 2004-05-12 EP claimed
EP-1351565-A1 CHEMICAL INHIBITORS OF MISMATCH REPAIR Morphotek Inc. (US) 2003-10-15 EP claimed
US-20030143586-A1 Genetic hypermutability of plants for gene discovery and diagnosis MORPHOTEK, INC. 2003-07-31 US claimed
US-20030091997-A1 Chemical inhibitors of mismatch repair EISAI, INC. 2003-05-15 US claimed
WO-2003031937-A2 GENETIC HYPERMUTABILITY OF PLANTS FOR GENE DISCOVERY AND DIAGNOSIS MORPHOTEK, INC. (US) 2003-04-17 WO claimed
US-20030068808-A1 Methods for generating antibiotic resistant microbes and novel antibiotics MORPHOTEK, INC. 2003-04-10 US claimed
WO-2003012130-A1 METHODS FOR GENERATING ANTIBIOTIC RESISTANT MICROBES AND NOVEL ANTIBIOTICS MORPHOTEK INC. (US) 2003-02-13 WO claimed
WO-2002054856-A1 CHEMICAL INHIBITORS OF MISMATCH REPAIR MORPHOTEK INC. (US) 2002-07-18 WO claimed
US-11434322-B2 Sulfobetaine group-comprising reactive compound, polymer thereof, and method of producing the polymer NAGASE CHEMTEX CORPORATION (JP) 2022-09-06 US disclosed
EP-3604275-B1 SULFOBETAINE-GROUP-CONTAINING REACTIVE COMPOUND, POLYMER THEREOF, AND METHOD FOR PRODUCING POLYMER NAGASE CHEMTEX CORP (JP) 2022-02-16 EP disclosed
US-20200131300-A1 SULFOBETAINE GROUP-CONTAINING REACTIVE COMPOUND, POLYMER THEREOF, AND METHOD FOR PRODUCING POLYMER NAGASE CHEMTEX CORPORATION (JP) 2020-04-30 US disclosed
WO-2003031937-A2 GENETIC HYPERMUTABILITY OF PLANTS FOR GENE DISCOVERY AND DIAGNOSIS MORPHOTEK, INC. (US) 2003-04-17 WO disclosed
US-20030068808-A1 Methods for generating antibiotic resistant microbes and novel antibiotics MORPHOTEK, INC. 2003-04-10 US disclosed
WO-2003012130-A1 METHODS FOR GENERATING ANTIBIOTIC RESISTANT MICROBES AND NOVEL ANTIBIOTICS MORPHOTEK INC. (US) 2003-02-13 WO disclosed
WO-2002054856-A1 CHEMICAL INHIBITORS OF MISMATCH REPAIR MORPHOTEK INC. (US) 2002-07-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131300-A1 SULFOBETAINE GROUP-CONTAINING REACTIVE COMPOUND, POLYMER THEREOF, AND METHOD FOR PRODUCING POLYMER CBR3, SCO2, MSRB3 NQO1 1236/4885CYP2A6 1665/4885CYP1A2 1895/4885
US-11434322-B2 Sulfobetaine group-comprising reactive compound, polymer thereof, and method of producing the polymer CBR3, SCO2, MSRB3 NQO1 1355/4885CYP2A6 1981/4885CYP1A2 2145/4885
US-20030091997-A1 Chemical inhibitors of mismatch repair MSH2, MSH6, PMS2 NQO1 783/4885CYP2A6 2364/4885CYP1A2 2746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.